Related Experiment Videos
Acid inhibition in GERD-how much is enough?
The American Journal of Gastroenterology
|June 8, 2004
Summary
Proton pump inhibitors (PPIs) may not fully normalize 24-hour intraesophageal pH in some gastro-esophageal reflux disease (GERD) patients, even with symptom control. This suggests potential for inadequate acid control despite effective symptom management in GERD.
Area of Science:
- Gastroenterology
- Acid-related disorders
- Esophageal physiology
Background:
- Gastric acid is crucial in gastro-esophageal reflux disease (GERD) pathogenesis.
- Proton pump inhibitors (PPIs) are standard therapy for GERD.
- Milkes et al. investigated PPI efficacy in normalizing intraesophageal pH in GERD patients.
Discussion:
- A significant proportion of H. pylori-negative GERD patients failed to achieve normalized 24-hour intraesophageal pH despite PPI therapy.
- This failure correlated with insufficient gastric acid inhibition.
- The clinical significance of non-normalized pH, regarding mucosal injury or complications, remains unclear.
Key Insights:
- PPI therapy may not normalize intraesophageal pH in all GERD patients, indicating potential for suboptimal acid control.
- Inadequate gastric acid inhibition is linked to the failure to normalize pH parameters.
- The study highlights a gap in understanding the correlation between pH normalization and actual esophageal mucosal health.
Outlook:
- Further research is needed to determine the optimal level and duration of acid inhibition for GERD healing and complication prevention.
- Investigating the correlation between esophageal pH normalization and endoscopic findings is crucial.
- Understanding the clinical relevance of non-normalized pH in a broader GERD population is essential.